NOVO B — Novo Nordisk A/S Share News
0.000.00%
Last trade - 00:00- DKK1.27tn
- DKK1.40tn
- DKK309.06bn
UK Stocks-Factors to watch on June 12
Brief: Novo Nordisk reports patient data breach from some clinical trials in IT security incident
Novo Nordisk flags patient data breach from some clinical trials in cyberattack (updated)
Novo Nordisk says security incident has access to limited internal IT systems
Brief: Novo Nordisk Identifies IT Security Incident; Core Business Operations Not Impacted
Brief: Novo Nordisk Sees Wegovy To Be Available In UK Via Private Prescription Within Weeks
UK approves Novo weight-loss pill to edge open European market (updated)
Novo Nordisk rises after UK health regulator approves its weight-loss pill
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Race to launch weight-loss pill heats up as Novo wins UK approval
Brief: UK's MHRA Authorises Novo Nordisk's Wegovy as First GLP‑1 Tablet for Weight Loss
UK health regulator approves Novo Nordisk's weight-loss pill
Some US employers to drop coverage of GLP-1 obesity drugs in 2027 as use increases
Novo Nordisk faces off in court with South African weight-loss drug compounder (updated)
Novo Nordisk faces off in court with South African weight-loss drug compounder
Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Brief: Novo Nordisk Introduces Updated Rybelsus® Tablet Formulation In Canada For Adults Living With Type 2 Diabetes
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Major deals involving US drugmakers and biotechs over the past decade